187 related articles for article (PubMed ID: 37483327)
1. Urinary Cytokines as Potential Biomarkers of Mild Cognitive Impairment and Alzheimer's Disease: A Pilot Study.
Saiyed N; Yilmaz A; Vishweswariah S; Maiti AK; Ustun I; Bartolone S; Brown-Hughes T; Thorpe RJ; Osentoski T; Ruff S; Pai A; Maddens M; Imam K; Graham SF
J Alzheimers Dis Rep; 2023; 7(1):649-657. PubMed ID: 37483327
[TBL] [Abstract][Full Text] [Related]
2. ApoE4 effects on automated diagnostic classifiers for mild cognitive impairment and Alzheimer's disease.
Apostolova LG; Hwang KS; Kohannim O; Avila D; Elashoff D; Jack CR; Shaw L; Trojanowski JQ; Weiner MW; Thompson PM;
Neuroimage Clin; 2014; 4():461-72. PubMed ID: 24634832
[TBL] [Abstract][Full Text] [Related]
3. Olfactory function changes and the predictive performance of the Chinese Smell Identification Test in patients with mild cognitive impairment and Alzheimer's disease.
Mi Y; Ma X; Du S; Du C; Li X; Tan H; Zhang J; Zhang Q; Shi W; Zhang G; Tian Y
Front Aging Neurosci; 2023; 15():1068708. PubMed ID: 36861124
[TBL] [Abstract][Full Text] [Related]
4. Influence of plasma matrix metalloproteinase levels on longitudinal changes in Alzheimer's disease (AD) biomarkers and cognitive function in patients with mild cognitive impairment due to AD registered in the Alzheimer's Disease Neuroimaging Initiative database.
Abe K; Chiba Y; Hattori S; Yoshimi A; Asami T; Katsuse O; Suda A; Hishimoto A;
J Neurol Sci; 2020 Sep; 416():116989. PubMed ID: 32603972
[TBL] [Abstract][Full Text] [Related]
5. Resting state EEG biomarkers of cognitive decline associated with Alzheimer's disease and mild cognitive impairment.
Meghdadi AH; Stevanović Karić M; McConnell M; Rupp G; Richard C; Hamilton J; Salat D; Berka C
PLoS One; 2021; 16(2):e0244180. PubMed ID: 33544703
[TBL] [Abstract][Full Text] [Related]
6. Targeted Metabolic Profiling of Urine Highlights a Potential Biomarker Panel for the Diagnosis of Alzheimer's Disease and Mild Cognitive Impairment: A Pilot Study.
Yilmaz A; Ugur Z; Bisgin H; Akyol S; Bahado-Singh R; Wilson G; Imam K; Maddens ME; Graham SF
Metabolites; 2020 Aug; 10(9):. PubMed ID: 32878308
[TBL] [Abstract][Full Text] [Related]
7. White matter signal abnormality quality differentiates mild cognitive impairment that converts to Alzheimer's disease from nonconverters.
Lindemer ER; Salat DH; Smith EE; Nguyen K; Fischl B; Greve DN;
Neurobiol Aging; 2015 Sep; 36(9):2447-57. PubMed ID: 26095760
[TBL] [Abstract][Full Text] [Related]
8. Potential Diagnostic Applications of Multi-Delay Arterial Spin Labeling in Early Alzheimer's Disease: The Chinese Imaging, Biomarkers, and Lifestyle Study.
Sun M; Wang YL; Li R; Jiang J; Zhang Y; Li W; Zhang Y; Jia Z; Chappell M; Xu J
Front Neurosci; 2022; 16():934471. PubMed ID: 35937865
[TBL] [Abstract][Full Text] [Related]
9. Identification and diagnostic potential of serum microRNAs as biomarkers for early detection of Alzheimer's disease.
Han YH; Xiang HY; Lee DH; Feng L; Sun HN; Jin MH; Kwon T
Aging (Albany NY); 2023 Nov; 15(21):12085-12103. PubMed ID: 37916989
[TBL] [Abstract][Full Text] [Related]
10. The Differential Diagnostic Value of the Callosal Angle and Evans Index in Mild Cognitive Impairment and Alzheimer's Disease.
Liu M; Zhang J; Zong L; Fan W; Wang B; Chen Z
Curr Med Imaging; 2021; 17(7):889-896. PubMed ID: 33357199
[TBL] [Abstract][Full Text] [Related]
11. P-tau231 as a Diagnostic Biomarker for Alzheimer's Disease and Mild Cognitive Impairment: A Systematic Review and Meta-Analysis.
Nabizadeh F; Salehi N; Ramezannezhad E; Sadeghmousavi S; Khalili E
Ann Indian Acad Neurol; 2022; 25(5):845-851. PubMed ID: 36560987
[TBL] [Abstract][Full Text] [Related]
12. Circulating microRNAs as Biomarkers of Alzheimer's Disease: A Systematic Review.
Wu HZ; Ong KL; Seeher K; Armstrong NJ; Thalamuthu A; Brodaty H; Sachdev P; Mather K
J Alzheimers Dis; 2016; 49(3):755-66. PubMed ID: 26484928
[TBL] [Abstract][Full Text] [Related]
13. Global N-acetylaspartate in normal subjects, mild cognitive impairment and Alzheimer's disease patients.
Glodzik L; Sollberger M; Gass A; Gokhale A; Rusinek H; Babb JS; Hirsch JG; Amann M; Monsch AU; Gonen O
J Alzheimers Dis; 2015; 43(3):939-47. PubMed ID: 25125458
[TBL] [Abstract][Full Text] [Related]
14. Cerebral Blood Flow Predicts Conversion of Mild Cognitive Impairment into Alzheimer's Disease and Cognitive Decline: An Arterial Spin Labeling Follow-up Study.
Duan W; Zhou GD; Balachandrasekaran A; Bhumkar AB; Boraste PB; Becker JT; Kuller LH; Lopez OL; Gach HM; Dai W
J Alzheimers Dis; 2021; 82(1):293-305. PubMed ID: 34024834
[TBL] [Abstract][Full Text] [Related]
15. 18F PET with flutemetamol for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).
Martínez G; Vernooij RW; Fuentes Padilla P; Zamora J; Flicker L; Bonfill Cosp X
Cochrane Database Syst Rev; 2017 Nov; 11(11):CD012884. PubMed ID: 29164602
[TBL] [Abstract][Full Text] [Related]
16. Non-invasive biomarkers for mild cognitive impairment and Alzheimer's disease.
Botello-Marabotto M; Martínez-Bisbal MC; Calero M; Bernardos A; Pastor AB; Medina M; Martínez-Máñez R
Neurobiol Dis; 2023 Oct; 187():106312. PubMed ID: 37769747
[TBL] [Abstract][Full Text] [Related]
17. 18F PET with florbetapir for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).
Martínez G; Vernooij RW; Fuentes Padilla P; Zamora J; Bonfill Cosp X; Flicker L
Cochrane Database Syst Rev; 2017 Nov; 11(11):CD012216. PubMed ID: 29164603
[TBL] [Abstract][Full Text] [Related]
18. Blood phosphorylated tau 181 as a biomarker for Alzheimer's disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts.
Karikari TK; Pascoal TA; Ashton NJ; Janelidze S; Benedet AL; Rodriguez JL; Chamoun M; Savard M; Kang MS; Therriault J; Schöll M; Massarweh G; Soucy JP; Höglund K; Brinkmalm G; Mattsson N; Palmqvist S; Gauthier S; Stomrud E; Zetterberg H; Hansson O; Rosa-Neto P; Blennow K
Lancet Neurol; 2020 May; 19(5):422-433. PubMed ID: 32333900
[TBL] [Abstract][Full Text] [Related]
19. Validation study of the Alzheimer's Disease Assessment Scale-Cognitive Subscale for people with mild cognitive impairment and Alzheimer's disease in Chinese communities.
Yang H; Cheng Z; Li Z; Jiang Y; Zhao J; Wu Y; Gu S; Xu H
Int J Geriatr Psychiatry; 2019 Nov; 34(11):1658-1666. PubMed ID: 31347192
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
